rs61753095

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_152743.4(BRAT1):​c.699G>A​(p.Thr233Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.193 in 1,569,366 control chromosomes in the GnomAD database, including 31,752 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2278 hom., cov: 32)
Exomes 𝑓: 0.20 ( 29474 hom. )

Consequence

BRAT1
NM_152743.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.22
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 7-2543694-C-T is Benign according to our data. Variant chr7-2543694-C-T is described in ClinVar as [Benign]. Clinvar id is 585492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.22 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.205 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRAT1NM_152743.4 linkc.699G>A p.Thr233Thr synonymous_variant Exon 5 of 14 ENST00000340611.9 NP_689956.2 Q6PJG6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRAT1ENST00000340611.9 linkc.699G>A p.Thr233Thr synonymous_variant Exon 5 of 14 1 NM_152743.4 ENSP00000339637.4 Q6PJG6-1

Frequencies

GnomAD3 genomes
AF:
0.152
AC:
23120
AN:
152116
Hom.:
2270
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0414
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.190
Gnomad ASJ
AF:
0.148
Gnomad EAS
AF:
0.00366
Gnomad SAS
AF:
0.156
Gnomad FIN
AF:
0.248
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.207
Gnomad OTH
AF:
0.151
GnomAD3 exomes
AF:
0.175
AC:
39580
AN:
226326
Hom.:
4200
AF XY:
0.177
AC XY:
21563
AN XY:
121888
show subpopulations
Gnomad AFR exome
AF:
0.0362
Gnomad AMR exome
AF:
0.205
Gnomad ASJ exome
AF:
0.155
Gnomad EAS exome
AF:
0.00231
Gnomad SAS exome
AF:
0.154
Gnomad FIN exome
AF:
0.242
Gnomad NFE exome
AF:
0.210
Gnomad OTH exome
AF:
0.189
GnomAD4 exome
AF:
0.197
AC:
279673
AN:
1417132
Hom.:
29474
Cov.:
33
AF XY:
0.196
AC XY:
136937
AN XY:
698142
show subpopulations
Gnomad4 AFR exome
AF:
0.0342
Gnomad4 AMR exome
AF:
0.205
Gnomad4 ASJ exome
AF:
0.154
Gnomad4 EAS exome
AF:
0.00136
Gnomad4 SAS exome
AF:
0.160
Gnomad4 FIN exome
AF:
0.244
Gnomad4 NFE exome
AF:
0.212
Gnomad4 OTH exome
AF:
0.178
GnomAD4 genome
AF:
0.152
AC:
23141
AN:
152234
Hom.:
2278
Cov.:
32
AF XY:
0.152
AC XY:
11324
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.0416
Gnomad4 AMR
AF:
0.191
Gnomad4 ASJ
AF:
0.148
Gnomad4 EAS
AF:
0.00347
Gnomad4 SAS
AF:
0.154
Gnomad4 FIN
AF:
0.248
Gnomad4 NFE
AF:
0.208
Gnomad4 OTH
AF:
0.151
Alfa
AF:
0.177
Hom.:
1068
Bravo
AF:
0.142
Asia WGS
AF:
0.0810
AC:
279
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Apr 20, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 27, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 41% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 38. Only high quality variants are reported. -

Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.22
DANN
Benign
0.72
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61753095; hg19: chr7-2583328; COSMIC: COSV61396838; COSMIC: COSV61396838; API